RYTM
Rhythm Pharmaceuticals Inc
98.20$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -348,514.3% | -4,629.1% | -733.7% | -175.8% | -87.5% | -61.0% | |
| – | – | – | – | – | – | 1,971.4% | 36.7% | 7.1% | 2.3% | 1.2% | 0.7% | |
| – | – | – | – | – | – | 49,871.4% | 659.6% | 83.9% | 42.0% | 30.5% | 35.2% | |
| – | – | – | – | – | – | 49,202.9% | 651.7% | 86.1% | – | – | – | |
| – | – | – | – | – | – | -16,842.9% | 60.1% | -83.4% | 6.2% | 8.1% | -0.5% | |
| – | – | – | – | – | – | 611.4% | 172.3% | 18.1% | 0.1% | 0.0% | 0.5% | |
| – | – | – | – | – | – | 452,945.7% | -1,970.8% | 118.6% | -7.3% | -37.0% | -72.3% | |
| – | – | – | – | – | – | – | – | – | – | 3.1% | 2.8% | |
| – | – | – | – | – | – | 5,740.0% | 5,278.4% | 598.6% | – | – | – | |
| – | – | – | – | – | – | – | – | 306.0% | – | – | – | |
| – | – | – | – | – | – | 5,740.0% | 5,278.4% | 904.6% | 96.0% | 147.0% | 114.9% | |
| – | – | – | – | – | – | 110,171.4% | -1,321.5% | 289.5% | -87.3% | 22.4% | -18.3% | |
| – | – | – | – | – | – | -349,125.7% | -4,801.4% | -751.8% | -175.9% | -87.5% | -61.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.